Everett Harris & Co. CA Acquires 517 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Everett Harris & Co. CA raised its holdings in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 3.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,828 shares of the medical instruments supplier’s stock after purchasing an additional 517 shares during the period. Everett Harris & Co. CA owned 0.41% of Utah Medical Products worth $1,249,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of UTMD. Acadian Asset Management LLC purchased a new position in shares of Utah Medical Products during the 1st quarter worth approximately $40,000. Osaic Holdings Inc. grew its stake in shares of Utah Medical Products by 22.3% in the 2nd quarter. Osaic Holdings Inc. now owns 646 shares of the medical instruments supplier’s stock worth $60,000 after buying an additional 118 shares during the last quarter. BNP Paribas Arbitrage SA grew its stake in shares of Utah Medical Products by 97.7% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 779 shares of the medical instruments supplier’s stock worth $67,000 after buying an additional 385 shares during the last quarter. Lazard Asset Management LLC grew its stake in shares of Utah Medical Products by 21.3% in the 1st quarter. Lazard Asset Management LLC now owns 837 shares of the medical instruments supplier’s stock worth $75,000 after buying an additional 147 shares during the last quarter. Finally, BNP Paribas Arbitrage SNC grew its stake in shares of Utah Medical Products by 33.5% in the 3rd quarter. BNP Paribas Arbitrage SNC now owns 1,040 shares of the medical instruments supplier’s stock worth $89,000 after buying an additional 261 shares during the last quarter. Institutional investors own 69.60% of the company’s stock.

Analyst Ratings Changes

UTMD has been the topic of several recent research reports. StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, March 7th. TheStreet downgraded Utah Medical Products from a “b-” rating to a “c+” rating in a research note on Monday, February 12th.

Utah Medical Products Trading Up 1.3 %

UTMD traded up $0.93 during trading on Thursday, hitting $71.11. 36,213 shares of the company’s stock traded hands, compared to its average volume of 26,599. The company’s 50 day simple moving average is $73.39 and its two-hundred day simple moving average is $79.90. Utah Medical Products, Inc. has a 12-month low of $68.00 and a 12-month high of $100.59. The stock has a market capitalization of $258.13 million, a price-to-earnings ratio of 15.36 and a beta of 0.12.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Tuesday, January 30th. The medical instruments supplier reported $1.18 EPS for the quarter. Utah Medical Products had a return on equity of 13.73% and a net margin of 33.12%. The business had revenue of $12.33 million for the quarter.

Utah Medical Products Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 3rd. Stockholders of record on Friday, March 15th will be issued a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, March 14th. This represents a $1.20 annualized dividend and a dividend yield of 1.69%. Utah Medical Products’s payout ratio is 26.26%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.